Kazia Therapeutics Ltd (KZIA)

[sanderburwil]

Kazia Therapeutics- $KZIA - Data-2019 SNO Conference OUT PFS 8.4 Months!!!!Expecting a $KRTX like move.
Temozolomide, Temodar (US) is the only FDA approved drug which extends patient lives from 4.4 months to 5.3 months. Kazia 8.4 is a huge success

We’re talking multi billion dollar market space here !!


CEO link on recent webcast suggest successful data here and co should be valued between 200-$500 million at this point of data is positive
Conservatively this is $45-$60 company given its potential and how easy and quick this will be FDA approved. They’re funded and they expect a “LARGER PHARMA” to bring GDC-0084 to fruition.


Dana Farber - Harvard Medical - MD Anderson - UCLA - Stephenson Cancer - John Theurer - Genetech

Poster Presenting Author(s)

Patrick Wen
Director, Center For Neuro-Oncology

ACTR-64 - Phase 2 study to evaluate the safety, pharmacokinetics and clinical activity of PI3K/mTOR inhibitor GDC-0084 in GBM patients with unmethylated O6-methylguanine-methyltransferase (MGMT) promoter status